ask="N/A"
ask_size="N/A"
average_daily_volume="33656"
bid="2.0000"
bid_size="100"
book_value="0.4940"
change="-0.0101"
change_from_200_day_moving_average="-0.7150"
change_from_50_day_moving_average="-0.4937"
change_from_52_week_high="-6.0201"
change_From_52_week_low="0.1799"
change_in_percent="-0.3378%"
close="2.9799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.4210"
ebitda="-15.65M"
eps_estimate_current_year="-1.6200"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-1.4900"
ex_dividend_date="N/A"
float_shares="5060000"
high="2.9900"
high_52_weeks="9.0000"
last_trade_date="2/1/2017"
last_trade_price="2.9799"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.8700"
low_52_weeks="2.8000"
market_capitalization="24.97M"
moving_average_200_day="3.6948"
moving_average_50_day="3.4736"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.5000"
open="2.9900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-19.3499%"
percent_change_from_50_day_moving_average="-14.2139%"
percent_change_from_52_week_high="-66.8900%"
percent_change_from_52_week_low="+6.4250%"
previous_close="2.9900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.0526"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.2900"
stock_exchange="NCM"
symbol="VTGN"
volume="26234"
weeks_range_52="2.8000 - 9.0000"
